Cimetidine-induced neutropenia: a possible dose-related phenomenon
- 1 May 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 139 (5) , 584-586
- https://doi.org/10.1001/archinte.139.5.584
Abstract
Neutropenia associated with high-dose cimetidine therapy developed in a patient in whom earlier therapy, as well as rechallenge with low-dose cimetidine, did not result in neutropenia. As other factors cannot be implicated, a dose-related toxicity of cimetidine appears likely. Although the mechanism of cimetidine-induced neutropenia is unkown, it may involve the previously demonstrated ability of histamine H2 receptor antagonists to block the histamine-induced initiation of DNA synthesis in bone marrow stem cells. Cimetidine is used in the treatment of gastrointestinal disorders.This publication has 3 references indexed in Scilit:
- Cimetidine and AgranulocytosisAnnals of Internal Medicine, 1978
- Transient Neutropenia in a Patient Receiving CimetidineGastroenterology, 1977
- Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cellInflammation Research, 1977